7Blamen H.The interaction beween PPI and orther drugs[J]Drug Safety,2006,29(9):769-770.
8Besancon M,Simon A,Sachsg,et al. Sites of reaction of the gastric H^+, K^+ -ATPase with extracytoplasmic thiol reagents[J]. Journal of Biological Chemistry, 1997, 272:22 438 - 22 446.
9Lerang F, Mourn B, Hang JB, et al. Highly effective twice a day triple therapies for Helicobacter pylori infection and peptic ulcer disase: metronidazole resistance is of only minor importance [J]. Gastroenterology, 1996, 110: A173.
10Welage LS, Berardi RR. Evaluation of Omeprazole. Lansopra - zole, Pantoprazole, in the treatment of acid related disease [ J ]. Jam Pharm Assoe Wash, 2000,40(1): 56 -62,121 - 123.
1Li H, Meng L, Liu F, et al. H '/KT -ATPase inhibitors; a patent review[ Jl. Expert 0pin Ther Pat, 2013,23 (1) : 99-111.
2Binnetoglu E, Akbal E, Sen H, et al. Pantoparazole-in-duced thrombocytopenia in patients with upper gastroine- testinal bleeding[ J]. Platelets, 2015,26( I ) :10-12.
3Wang X, Fang J Y, Lu R, et al. A meta-analysis: com- parison of esomeprazole and other proton pump inhibitors in eradicating Helicobacter pylori[ J ]. Digstion, 2006,73 (2-3) :178-186.
4Devault K R. Pantoprazole: a proton pump inhibitor with oral and intravenous formulations [ J ]. Expert Rev Gastro- enterol Hepatol, 2007,1 (2) : 197-205.
5American Society of Health-System Pharmacists. ASHP Therapeutic Guidelines on Stress Ulcer Prophylaxis. ASHP Commission on Therapeutics and approved by the ASHP Board of Directors on November 14, 1998 [ J]. Am J Health Syst Pharm, 1999,56 (4) :347-379.
